CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined.
^ abKang ES, Park CW, Chung JH (Dec 2001). "Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1". Biochem. Biophys. Res. Commun.289 (4): 862–8. doi:10.1006/bbrc.2001.6057. PMID11735126.
Xu GL, Bestor TH, Bourc'his D, et al. (2000). "Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.". Nature402 (6758): 187–91. doi:10.1038/46052. PMID10647011.
Kang ES, Park CW, Chung JH (2002). "Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.". Biochem. Biophys. Res. Commun.289 (4): 862–8. doi:10.1006/bbrc.2001.6057. PMID11735126.
Deloukas P, Matthews LH, Ashurst J, et al. (2002). "The DNA sequence and comparative analysis of human chromosome 20.". Nature414 (6866): 865–71. doi:10.1038/414865a. PMID11780052.
Rhee I, Bachman KE, Park BH, et al. (2002). "DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.". Nature416 (6880): 552–6. doi:10.1038/416552a. PMID11932749.
Hata K, Okano M, Lei H, Li E (2002). "Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice.". Development129 (8): 1983–93. PMID11934864.
Beaulieu N, Morin S, Chute IC, et al. (2002). "An essential role for DNA methyltransferase DNMT3B in cancer cell survival.". J. Biol. Chem.277 (31): 28176–81. doi:10.1074/jbc.M204734200. PMID12015329.
Shen H, Wang L, Spitz MR, et al. (2002). "A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.". Cancer Res.62 (17): 4992–5. PMID12208751.
Shirohzu H, Kubota T, Kumazawa A, et al. (2003). "Three novel DNMT3B mutations in Japanese patients with ICF syndrome.". Am. J. Med. Genet.112 (1): 31–7. doi:10.1002/ajmg.10658. PMID12239717.